(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

S SOPHARMA

This trademark appears in the official USPTO history.

Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type: CombinedOffice: United States

Quick snapshot

S SOPHARMA

ST13

US500000076571645

Class

5

Filing

76571645

Registration

3039075

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Case type

Application and registration

Recorded events

34

Latest update

07/24/2026

Trademark type

Combined

Nice classes

5

Filing date

01/23/2004

Registration date

01/10/2006

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/24/2026

Last transaction

07/24/2026

Responsible office

United States Patent and Trademark Office

Status code

710

Official register

Principal Register

First use anywhere

06/03/1993

First use in commerce

06/03/1993

Drawing code

3

Owner type

03

Owner location

Sofia, BG

Examiner

MADDEN, ANNE

Law office

L30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

S. A. (pessoa física)

Representatives

Nicholas D. Wells Legends Law Group, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationspreparations for treatment of peripheral neuritis and neuralgia and treatment of neurological disordersphysical and mental fatigue; tonics for the nervous system; capillartonics; anti-inflammatory preparations and preparations for treatment of arteryvein and capillary diseases; nutritional supplements for improving and regulating metabolism in epithelial cells to protect them from degenerative alterations; nutritional supplements for enhancing and maintaining the status of the immune system; nutritional supplements for influencing chronic hepatitisdystrophies and damage of the liver; dietetic substances adapted for medical use

Publications

History of USPTO decisions and trademark events.

34 publications found

CAEX

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

07/24/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/26/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/26/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/18/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/18/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/18/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/17/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

01/11/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/11/2016

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/05/2012

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/05/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/01/2012

ES8R

TEAS SECTION 8 RECEIVED

01/10/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/30/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

01/10/2006

PUBO

PUBLISHED FOR OPPOSITION

10/18/2005

NPUB

NOTICE OF PUBLICATION

09/28/2005

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/06/2005

ALIE

ASSIGNED TO LIE

07/01/2005

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/29/2005

ACEC

AMENDMENT FROM APPLICANT ENTERED

05/26/2005

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/17/2005

MAIL

PAPER RECEIVED

05/17/2005

ACEC

AMENDMENT FROM APPLICANT ENTERED

03/16/2005

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2005

MAIL

PAPER RECEIVED

03/01/2005

CNRT

NON-FINAL ACTION MAILED

09/01/2004

CNRT

SU - NON-FINAL ACTION - WRITTEN

08/31/2004

DOCK

ASSIGNED TO EXAMINER

08/14/2004

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

05/05/2004

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/05/2004

MAIL

PAPER RECEIVED

05/05/2004

NWAP

NEW APPLICATION ENTERED

02/10/2004

Continuous trademark protection

Get notified about every new filing that threatens S SOPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.